The choice of reverse- or forward-mode pipetting is often based on operator preference, but choosing the right technique can help to minimize error in
automated liquid handling.
The U.S. Court of Appeals for the Federal Circuit recently rendered a decision in Ortho-McNeil Pharmaceutical Inc. v. Lupin Pharmaceuticals Inc.
on the question of whether separate enantiomers can have “first commercial marketing or use” status for purposes of patent term extension under 35 U.S.C. §
156.
With many of us gathering on the
fourth of this month to celebrate the birth of our country, it’s a good time to assess the state of U.S. pharma and biotech markets.
Micronic offers a full
range of biological and cryogenic sample storage tubes, sealing arrangements, tube racks, tube sorters and Track-IT—a new sample management system interfaced
to a 2D code reader that allows users to reliably and efficiently organize and track individual samples.
Bio-Rad Laboratories Inc. introduces SsoFast probes supermix, a reagent that enables researchers using fluorogenic probes to
enhance the speed, reliability and sensitivity of their qPCR experiments.
Shimadzu Scientific Instruments has taken the wraps off several new products,
including AXIMA MegaTOF, an integrated MALDI solution from Shimadzu and CovalX for ultra high-mass applications that detect intact complexes up to 1.5 MDa.;
Nexera Ultra High-Performance Liquid Chromatograph, which meets all analysis requirements with no compromise in data integrity; Nanotrap Biomarker Discovery
Platform, which gives researchers the ability to enrich, preserve and screen low-level biomarkers directly from complex biological samples; and Component ID
Solution, software that accelerates high-confidence component identification using the power of high-mass accuracy and the simplicity of an open-access
workflow.
GripTips are a next-
generation range of pipette tips that ensure the perfect connection between pipette and tip. GripTips have been engineered to provide unmatched high lateral
resistance.
Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (rHu GM-CSF) is produced in response to a number of
inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation.
Affomix and the PGx Centre to develop reagents that will enable the quantitative multiplexed profiling of strategic proteins predictive of drug efficacy and
toxicity
Clovis Oncology and Avila Therapeutics sign $209 million agreement for the worldwide development and commercialization of EGFR mutant-selective
inhibitor
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.